News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Association between TIL and survival in patients with MBC receiving first-line chemotherapy
Photo taken from Daniel Stover/X
Sep 9, 2024, 11:46

Association between TIL and survival in patients with MBC receiving first-line chemotherapy

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a paper by Daniel Stover et al. on X, adding:

“Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502.

  • To evaluate the association of sTILs with progression-free survival in randomized phase III trial CALGB 40502.
  • sTILs were associated with progression-free and overall survival in chemotherapy-treated MBC when controlling for treatment arm; however, this effect did not remain significant after additional adjustment for hormone receptor status.”

Elisabetta Bonzano

Source: Elisabetta Bonzano/X

Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502.

Authors: Daniel G. Stover, Roberto Salgado, Oleksander Savenkov, Karla Ballman, Erica L. Mayer, Mark Jesus M. Magbanua, Sherene Loi, Mark Vater, Kristyn Glover, Mark Watson, Yujia Wen, W. Fraser Symmans, Charles Perou, Lisa A. Carey, Ann H. Partridge and Hope S. Rugo.

patients

 

Ann H. Partridge Breast Cancer CALGB 40502 cancer Charles Perou chemotherapy Daniel G. Stover Elisabetta Bonzano Erica L. Mayer Hope S. Rugo Karla Ballman Kristyn Glover Lisa A. Carey Mark Jesus M. Magbanua Mark Vater Mark Watson Oleksander Savenkov OncoDaily Oncology Roberto Salgado Sherene Loi W. Fraser Symmans Yujia Wen
Special Coverage
Insight
Nov 3, 2024, 17:46
Rana McKay: Evaluating ACP1 expression in prostrate cancer
Insight
Nov 3, 2024, 17:23
Talha Badar: A predictive model for therapy failure in patients with CML receiving TKI therapy
Insight
Nov 3, 2024, 17:05
Vincent Rajkumar: Survival improvement in patients with HIV associated B cell lymphoma that adopted the Medicaid expansion of ACA
Blog
Nov 3, 2024, 16:51
Addressing cancer disparities among Black women - American Cancer Society
Blog
Nov 3, 2024, 16:48
Mohit Manrao: Discussing cancer innovation and biomarkers at the STAT Summit
Blog
Nov 3, 2024, 16:46
Lindsey Gasparini: New FDA-approved therapy targets Claudin18.2 in gastric cancers
Blog
Nov 3, 2024, 16:45
Nermean Mostafa: Launching a new oncology training platform in Egypt
Blog
Nov 3, 2024, 16:35
Jasmine Kamboj: Honored to be on the ballot for the Designated Community Oncology seat
Blog
Nov 3, 2024, 16:34
Crystal Denlinger: Our biannual guidelines harmonization update meeting
Blog
Nov 3, 2024, 16:30
Yale University's $150M investment into AI leadership is equipping medstudents with the tools to tackle tomorrow's healthcare challenges
Insight
Nov 3, 2024, 16:27
Alessandro Di Federico: EFS in patients with resectable NSCLC treated with neoadjuvant Chemo-IO
Blog
Nov 3, 2024, 16:25
Raising awareness on biomarker information gaps for metastatic breast cancer patients - ABC Global Alliance